GlassScriptPhysician profile
Aneesh A Kothare
NPI 1184114415
$696.33
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $239 · 2024: $278 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $162.16 | 2022 | |
| Innovation Technologies INC | $157.07 | 2024 | Irrisept |
| Hologic Sales and Service, LLC | $102.04 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Astellas Pharma US INC | $79.40 | 2024 | Veozah |
| Baxter Healthcare | $46.47 | 2025 | Perclot |
| Medtronic, INC. | $39.31 | 2022 | |
| Smith+Nephew, INC. | $37.49 | 2022 | |
| Optumhealth Care Solutions, LLC | $21.93 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Shield Therapeutics INC | $19.19 | 2025 | |
| Coopersurgical, INC. | $16.74 | 2025 | Sos |
| Biogen, INC. | $14.53 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneesh Kothare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.